Scientists discover glioblastoma growth ties to daily hormone rhythms, impacting treatment timing.
Scientists found that glioblastoma, a deadly brain cancer, syncs its growth with the body's daily hormone rhythms, especially glucocorticoids. This discovery suggests that the timing of dexamethasone, a common treatment, is crucial; evening doses may suppress tumor growth, while morning doses could promote it. Patients with fewer glucocorticoid receptors in their tumors tend to live longer, hinting at new timing-based therapies.
4 months ago
5 Articles
You have 9 free stories remaining this month. Subscribe anytime for unlimited access.